• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

    4/10/25 8:30:00 AM ET
    $CTEV
    Business Services
    Consumer Discretionary
    Get the next $CTEV alert in real time by email

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time.

    To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time.

    To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0d49d&confId=80335.

    A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck will also be available on this section of the Company's website.

    For those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company's website. For those requiring operator assistance please dial (404) 975-4839 or (833) 470-1428. The access code is 685315.

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-built solutions that support all key stakeholders – including payors, employers, patients, providers, and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250410467046/en/

    Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]



    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Claritev upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Claritev from Neutral to Overweight and set a new price target of $44.00

      5/29/25 8:13:13 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    SEC Filings

    See more
    • SEC Form S-8 filed by Claritev Corporation

      S-8 - Claritev Corp (0001793229) (Filer)

      5/9/25 8:05:24 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Claritev Corporation

      10-Q - Claritev Corp (0001793229) (Filer)

      5/9/25 7:40:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      5/8/25 6:04:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Claritev Joins athenahealth's Marketplace Program to Empower Providers with Price Intelligence for Stronger Financial Outcomes

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with athenahealth, Inc. through the company's award-winning athenahealth® Marketplace program. Now available to athenahealth's growing network of healthcare providers, the newly integrated CompleteVue™ enables financial impact through the power of publicly available price transparency data, actionable insights and powerful analytics. The athenahealth Marketplace empowers athenahealth customers to easily discover and implement solutions that meet their unique needs, fostering

      7/17/25 3:45:00 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Releases 2024 Corporate Responsibility Report

      Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

      7/16/25 9:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter 2025 financial results on Wednesday, August 6, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/eve

      7/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Financials

    Live finance-specific insights

    See more
    • Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter 2025 financial results on Wednesday, August 6, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/eve

      7/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0

      4/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Leadership Updates

    Live Leadership Updates

    See more
    • Claritev Releases 2024 Corporate Responsibility Report

      Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

      7/16/25 9:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

      Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

      5/28/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary